Please login to the form below
dermatology
This page shows the latest dermatology news and features for those working in and with pharma, biotech and healthcare.
Novartis gains label boost for Cosentyx
We are reimagining the well-being of patients living with all facets of psoriatic arthritis," said Eric Hughes, Global Development Unit Head, Immunology, Hepatology and Dermatology.
Latest news
-
Big Pharma, Little Pharma
The company took a big risk when it bought Allergan’s dermatology portfolio.
-
New data keeps AbbVie’s star pipeline therapies on track
AbbVie has presented new data on its risankizumab candidate in psoriasis and upadacitinib in atopic dermatitis that suggest it has a potentially lucrative dermatology franchise on the way. ... At the European Academy of Dermatology and Venereology (EADV)
-
Novartis sells off part of Sandoz portfolio
The move, which will see Sandoz do away with its lower margin segments of US dermatology and generic oral solid portfolios, allows the firm to re-focus its business. ... In return Aurobindo is set to receive approximately 300 products, as well as
-
Realm toppled by second mid-stage trial flop
The company also thinks that its hypochlorous acid formulations could have potential “in immune-mediated diseases generally,” although programmes outside of dermatology are at the very early stages of development.
-
FDA gives breakthrough status to Xolair for food allergies
Since then Roche and Novartis have built on the drug’s approved uses, expanding its label in allergic asthma and adding a dermatology indication – the treatment of chronic idiopathic urticaria (hives) –
More from news
Approximately 11 fully matching, plus 161 partially matching documents found.
Latest Intelligence
-
Deal Watch October 2018
in 2018, and includes 300 products, development projects, branded dermatology products and the dermatology development centre and three manufacturing sites in the US. ... Roche. Oral solid generics and dermatology business. Collaboration. $1.375B. Sandoz/
-
Leo has its eyes on the prize
More than a century has passed since the Nobel Prize in Medicine was awarded for dermatology. ... There are huge unmet needs and the predictions are that the dermatology market will grow significantly over the coming years.
-
Deal Watch January 2018
Royalty monetisation. 230. Jiangsu Hengrui Medicine/Arcutis. SHR0302, selective JAK inhibitor, for dermatology disorders (currently p2 for RA in China).
-
Pharma deals continue to slide
Roche has licensed a monoclonal antibody in phase II to Dermira, a dermatology company.
-
Deal Watch September 2016
The Vitae acquisition builds Allergan's dermatology pipeline with VTP-43742, a mid stage, orally active RORγt (retinoic acid receptor-related orphan receptor gamma) inhibitor for the potential treatment of psoriasis,
More from intelligence
Approximately 0 fully matching, plus 35 partially matching documents found.
Latest appointments
-
New hires at Nanoform, Leo Pharma and Calliditas
Leo Pharma boosts Translational Medicine team. Adam Raff will soon join dermatology-focused Leo Pharma, heading up the company’s new Translational Medicine Unit as director and medical advisor. ... Raff currently works as a dermatologist at the
-
Dermavant strengthens executive team
Peterson, who previously worked at Sienna Biopharmaceuticals as its chief financial officer, comes to Dermavant Sciences with experience in the dermatology space.
-
Leo Pharma appoints new senior vice president
vice president, dermatology value stream at Leo.
-
Concept Life Sciences adds to its scientific and commercial team
Concept Life Sciences has appointed Dr Michael Donaldson (pictured right) as its principal scientist in its dermal department, a role that will see him take responsibility for its dermatology services. ... With over 17 years’ experience in the
-
Ron Menezes joins Almirall’s Aqua Pharmaceuticals
Amirall's US dermatology company Aqua Pharmaceuticals has appointed Ron Menezes as its new president and general manager. ... Ron’s incorporation and he experience he brings in dermatology represent a clear and undeniable opportunity to further
More from appointments
Approximately 1 fully matching, plus 27 partially matching documents found.
Latest from PMHub
-
Porterhouse Medical Group adds to its growing team of scientific and medical experts
Claire also has plenty of experience managing digital projects and events across a range of therapy areas, including women’s health, diabetes, haematology, oncology, urology, dermatology and asthma.
-
Psoriasis Drugs Market To Make Great Impact In Near Future by 2028
The North America psoriasis drugs market is expected to expand at significant CAGR and to be the dominant revenue-generating psoriasis drugs market due to large presence of dermatology clinics and
-
Trio of Communiqué Awards for Havas Lynx
After many setbacks patients no longer think this is achievable, but the good news is that – thanks to advances in dermatology – it is now possible. .
-
How integrated insights supported a biologic launch strategy across multiple indications
Our client is launching a new biologic in dermatology across indications and needed to understand the market, including the patient pool, treatment landscape, potential uptake and pricing opportunity for their new
-
The Biosimilar Challenge
The pressure is now on to undertake the same in rheumatology, dermatology and oncology, where large volumes of patients will yield huge savings for the CCG.
More from PMHub
Approximately 2 fully matching, plus 14 partially matching documents found.
Featured jobs
-
Account Director
-
Competitive Salary Offered
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
- Senior Account Director development role to Business Director, H...
-
Excellent package
-
Associate Director
-
£75, 000-90, 000
-
Senior Medical Writer
-
Salary TBC
-
Senior Account Manager
-
Competitive Salary Offered
- Global Business Development Director – Health Education
-
excellent commission
-
Account Director, Medical Education
-
Salary TBC
- Senior Account Manager, Rare Diseases – Medical Communications, ...
-
Excellent package
- Engagement Expert, Healthcare Brand Communications, London
-
Excellent package
- Editorial Assistant Medical Education Agency
-
£25, 000 - £26, 000
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Account Manager / Account Director
-
Competative
-
Business Director
-
Competitive Salary Offered
-
Medical Writer
-
Salary TBC
Subscribe to our email news alerts
PMHub
Consulting at McCann Health
We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...
Latest intelligence
- The UK’s new five-year pricing agreement
- Pharma has agreed to capped growth again - in exchange for uptake promises...
- Digital applications are transforming the market access landscape
- Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....
- Escaping the spin cycle of sub-optimal launch
- ...
Quick links
Infographics
